@Trulieve: Authorized a share repurchase program in June 2026 for up to the lesser of $50M or ~8.5M subordinate voting shares (5% of O), running for 12 months through June 2027. Purchased shares will be cancelled. This coincided with its NYSE listing under the $TRLV ticker.
Canada’s legal cannabis market set a new monthly sales record in June at CA$517.8 million, bringing sales for the first half of 2026 to nearly CA$3 billion, according to new federal government data released today. https://t.co/aDzpGSUNok
Wake me up when #WallStreetBets realizes now that $TRLV is on the NYSE and has options, they can create one hell of a gamma squeeze
@wallstreetbets
$TRLV ➡️ $11.07
$JUNS ➡️ $6.20
July 28
Jupiter Neurosciences sells 11,470,000 shares to Yorkville for about $3.6 million in unregistered offering
This money was raised not even a month ago at the equivalent of $23 a share if you adjust it for today’s RS of 1-75
$JUNS ➡️ $5M MC
“The agreement includes an upfront payment of $3.3M ($1.5M in cash and $1.8M in Jupiter common stock), with additional development, regulatory, and commercial milestone totaling up to $96.7M”
$JUNS ➡️ $5M MC
https://t.co/4JqQZmyepw
“The transaction is valued at up to $100 million, including milestone payments, and expands Jupiter into a dual clinical-stage CNS company alongside its Phase II Parkinson's disease program”
$JUNS ➡️ $5M MC
https://t.co/4JqQZmyepw
“The transaction is valued at up to $100 million, including milestone payments, and expands Jupiter into a dual clinical-stage CNS company alongside its Phase II Parkinson's disease program”
Juniper #Neuroscience clearly had this offering planned ahead of today’s news The fact is was so small, as to not dilute shared holders, is bullish as fuck. The offering was finished before it even was announced.
The deal announced today is worth $100M
$JUNS ➡️ $5M MC
@Trulieve@villagefarms
If I had to venture a guess why Citadel owns approximately 5% of Village Farms it’s because they will be involved in an M&A transaction
My guess would be that Trulieve acquires Village Farms
$TRLV $VFF
$JUNS
The transaction is valued at up to $100 million, including milestone payments, and expands Jupiter into a dual clinical-stage CNS company alongside its Phase II Parkinson's disease program.
July 21, 2026
Jupiter Neurosciences, Inc. $JUNS signed a definitive license agreement with PharmAla Biotech Holdings Inc. (MDXXF) for perpetual exclusive U.S. rights to ALA-002, a patented non-racemic MDMA formulation designated as a Novel Chemical Entity (NCE) by the FDA.
@Trulieve will acquire either @tilray or @villagefarms
$TRLV $VFF $TLRY
I still think an announcement is coming today from #Trump. It’s the one sector. He’s yet to provide a boost too.!! 🚀
#Moderna (or #Merck as partner) could contact Novavax for an MTA to evaluate Matrix-M, followed by potential licensing negotiations if data support it. #Novavax supplies the adjuvant under its agreements and is open to such deals.
$NVAX $MRNA $MRK
$NVAX OTM 👀
FACTS
➡️ @sanofi the 6th largest pharmaceutical company owns 9.8% of #Novavax & has invested $1.2B
➡️ #Pfizer the largest pharmaceutical company has invested $653M
➡️ #Moderna’s #cancer vaccine would benefit from the #Nivavax’s adjuvant
➡️ SI ~30%
$NVAX OTM 👀
FACTS
➡️ @sanofi the 6th largest pharmaceutical company owns 9.8% of #Novavax & has invested $1.2B
➡️ #Pfizer the largest pharmaceutical company has invested $653M
➡️ #Moderna’s #cancer vaccine would benefit from the #Nivavax’s adjuvant
➡️ SI ~30%
#Trump will comment on cannabis reform today. Just watch.
$TLRY $VFF $CGC $ACB $CURA.TO
Interesting that #citadel reported a significant position in #villagefarms $VFF
$JUNS could be one of the biggest gainers today. 500% wouldn’t surprise me based on how these things have been trading and considering the move is based on bullish news.
➡️ $8.75
$JUNS could be one of the biggest gainers today. 500% wouldn’t surprise me based on how these things have been trading and considering the move is based on bullish news.
➡️ $8.75